Concepedia
Statistics
Publications
6
Citations
394
H-Index
Active since
2011
Affiliations
Dartmouth College(Current)
Cotton (United States)
Duksung Women's University
Ryan Montano is an author at Dartmouth College specializing in pharmacology, molecular oncology, and cancer pharmacology.
Publications per year
2011–2017
Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites
Ryan Montano, Injae Chung, Kristen M. Garner et al. · Molecular Cancer Therapeutics · 2011 · 119 citations · Full text
Medicine, Oncology, Pharmacology +17
Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo
Ryan Montano, Ruth Thompson, Injae Chung et al. · BMC Cancer · 2013 · 76 citations · Full text
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase
Nandini Sakurikar, Ruth Thompson, Ryan Montano et al. · Oncotarget · 2015 · 74 citations · Full text
The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition
Ruth Thompson, Ryan Montano, Alan Eastman · PLoS ONE · 2012 · 56 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor
Ryan Montano, Nadeem Khan, Huagang Hou et al. · Oncotarget · 2017 · 47 citations · Full text
Medicine, Cancer Biology, Pharmacology +17
1–5 of 6